Published in Drug Des Discov on January 01, 2000
Molecular recognition of opioid receptor ligands. AAPS J (2006) 0.95
Docking studies suggest ligand-specific delta-opioid receptor conformations. J Mol Model (2008) 0.78
Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods. J Mol Model (2010) 0.77
Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists. Nucl Med Biol (2010) 0.75
Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors. Eur J Med Chem (2016) 0.75
Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology (1996) 3.08
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem (2000) 2.96
An assay combining cell culture with reverse transcriptase PCR to detect and determine the infectivity of waterborne Cryptosporidium parvum. Appl Environ Microbiol (1997) 1.72
Strategies to maintain the credibility of sham acupuncture used as a control treatment in clinical trials. J Altern Complement Med (1997) 1.53
Epistasis between calpain 1 and its inhibitor calpastatin within breeds of cattle. Genetics (2007) 1.34
Chlorinated hydrocarbons and the environment. Endeavour (1975) 1.33
2,3-Dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists of the human galanin hGAL-1 receptor. Bioorg Med Chem (2000) 1.27
Integration of somatic and autonomic reactions within the midbrain periaqueductal grey: viscerotopic, somatotopic and functional organization. Prog Brain Res (1991) 1.12
Potent and selective indolomorphinan antagonists of the kappa-opioid receptor. J Med Chem (2000) 1.11
Analysis of the malondialdehyde-2'-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. Chem Res Toxicol (1997) 1.09
Mitomycin-induced lethality of Escherichia coli cells containing the ColE1 Plasmid: involvement of the kil gene. J Bacteriol (1985) 1.08
Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus. J Med Chem (2001) 1.08
Structural properties of DNA:RNA duplexes containing 2'-O-methyl and 2'-S-methyl substitutions: a molecular dynamics investigation. Nucleic Acids Res (1999) 1.05
Transformation of a kappa-opioid receptor antagonist to a kappa-agonist by transfer of a guanidinium group from the 5'- to 6'-position of naltrindole. J Med Chem (2001) 1.03
QSAR and CoMFA: a perspective on the practical application to drug discovery. Drug Des Discov (2000) 1.03
Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. J Med Chem (2000) 1.02
Conformational analysis of the eight-membered ring of the oxidized cysteinyl-cysteine unit implicated in nicotinic acetylcholine receptor ligand recognition. J Am Chem Soc (2001) 1.00
Colicin synthesis and cell death. J Bacteriol (1985) 0.99
Molecular design and modeling of protein-heparin interactions. Methods Enzymol (1991) 0.98
Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models. Neurochem Res (1996) 0.97
Comparison of 16S rRNA sequencing with conventional and commercial phenotypic techniques for identification of enterococci from the marine environment. J Appl Microbiol (2006) 0.95
Evaluation of antibiotic resistance analysis and ribotyping for identification of faecal pollution sources in an urban watershed. J Appl Microbiol (2005) 0.94
A new method for orthotopic rat liver transplantation with arterial cuff anastomosis to the recipient common hepatic artery. Transplantation (1989) 0.94
Synthesis of an eight-membered cyclic pseudo-dipeptide using ring closing metathesis. Org Lett (2001) 0.93
Functional characteristics of the parallel SI- and SII-projecting neurons of the thalamic ventral posterior nucleus in the marmoset. J Neurophysiol (2001) 0.92
Neural control of vocalization: respiratory and emotional influences. J Voice (1996) 0.92
Genetic and environmental effects on meat quality. Meat Sci (2010) 0.92
Quantitation of Cryptosporidium parvum infection in cell culture using a colorimetric in situ hybridization assay. J Eukaryot Microbiol (2001) 0.92
Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists. J Med Chem (1998) 0.89
Development of a rapid detection procedure for Cryptosporidium, using in vitro cell culture combined with PCR. J Eukaryot Microbiol (1996) 0.89
A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors. J Med Chem (1990) 0.89
Mephedrone ("bath salt") pharmacology: insights from invertebrates. Neuroscience (2012) 0.89
Stereochemistry and mechanism of the Wittig reaction. Diasteromeric reaction intermediates and analysis of the reaction course. J Am Chem Soc (1986) 0.89
On the role of extracellular loops of opioid receptors in conferring ligand selectivity. FEBS Lett (1995) 0.88
Ratio of hepatic arterial-to-portal venous blood flow--validation of radionuclide techniques in an animal model. J Nucl Med (1992) 0.87
A derivative of bisbenzylisoquinoline alkaloid is a new and potential calmodulin antagonist. Biochem Biophys Res Commun (1986) 0.86
In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum. J Pharmacol Exp Ther (1994) 0.85
Pulmonary and upper airway afferent influences on the motor pattern of vocalization evoked by excitation of the midbrain periaqueductal gray of the cat. Brain Res (1993) 0.84
The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216. J Pharmacol Exp Ther (2006) 0.84
Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation. J Med Chem (1997) 0.84
Conformational analysis of the endogenous mu-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling. FEBS Lett (1998) 0.83
Antisense strategies in neurobiology. Neurochem Int (1997) 0.83
Knowledge-based modeling of a bacterial dichloromethane dehalogenase. Proteins (1997) 0.83
Antinociceptive action of McN-5195 in rodents: a structurally novel (indolizine) analgesic with a nonopioid mechanism of action. J Pharmacol Exp Ther (1990) 0.83
Pharmacological treatment of obesity: therapeutic strategies. J Med Chem (1999) 0.83
Photodynamic action of actinomycin D: an EPR spin trapping study. Biochim Biophys Acta (2001) 0.82
Resting oxygen consumption and ventilation in cystic fibrosis. Pediatr Pulmonol (1989) 0.82
Primary structure similarity analysis of proteins sequences by a new graphical representation. SAR QSAR Environ Res (2014) 0.82
Reduced level of calmodulin in PC12 cells induced by stable expression of calmodulin antisense RNA inhibits cell proliferation and induces neurite outgrowth. Neuroscience (1996) 0.82
Potential anxiolytic agents. Pyrido[1,2-a]benzimidazoles: a new structural class of ligands for the benzodiazepine binding site on GABA-A receptors. J Med Chem (1995) 0.82
Capsaicin for allergic rhinitis in adults. Cochrane Database Syst Rev (2006) 0.82
Mitochondrial increase after long-term feeding of morfamquat. Nature (1969) 0.81
Cattle temperament: persistence of assessments and associations with productivity, efficiency, carcass and meat quality traits. J Anim Sci (2010) 0.81
Structural characteristics of 2'-O-(2-methoxyethyl)-modified nucleic acids from molecular dynamics simulations. Nucleic Acids Res (1998) 0.80
Recovery of fertility after removal of polyurethane plugs from the human vas deferens occluded for up to 5 years. Int J Androl (1992) 0.80
Stereochemical requirements for receptor recognition of the mu-opioid peptide endomorphin-1. Biophys J (2000) 0.80
Shape similarity comparison of protein CPK models based on improved L₁-medial skeleton. SAR QSAR Environ Res (2014) 0.80
HIV-1 reverse transcriptase inhibitor design using artificial neural networks. J Med Chem (1994) 0.80
Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA. Neuroscience (1993) 0.80
Applications of neural networks in structure-activity relationships of a small number of molecules. J Med Chem (1993) 0.79
The effect of arabinose 1,5-bisphosphate on rat hepatic 6-phosphofructo-1-kinase and fructose-1,6-bisphosphatase. Biochem Biophys Res Commun (1986) 0.79
Prepubertal periodontitis affecting the deciduous and permanent dentition in a patient with cyclic neutropenia. A case report and discussion. J Periodontol (1984) 0.79
Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA. Neurochem Int (1993) 0.79
Alpha(2) adrenoceptor agonists as potential analgesic agents. 3. Imidazolylmethylthiophenes. J Med Chem (2001) 0.79
Prediction of biodegradation rate constants of hydroxylated polychlorinated biphenyls by fungal laccases from Trametes versicolor and Pleurotus ostreatus. Bull Environ Contam Toxicol (2008) 0.79
Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle. J Pharmacol Exp Ther (1991) 0.78
Pyrazolecarboxamide human neuropeptide Y5 receptor ligands with in vivo antifeedant activity. Bioorg Med Chem Lett (2001) 0.78
Temperature and safety profiles of needle-warming techniques in acupuncture and moxibustion. Evid Based Complement Alternat Med (2012) 0.78
The effects of 12, 30, or 48 hours of road transport on the physiological and behavioral responses of sheep. J Anim Sci (2010) 0.78
Aminopyrazoles with high affinity for the human neuropeptide Y5 receptor. Bioorg Med Chem Lett (2001) 0.78
Oral phentolamine and female sexual arousal disorder: a pilot study. J Sex Marital Ther (1999) 0.78
Expression of a D2 dopamine receptor antisense RNA in brain inhibits D2-mediated behaviors. Neurochem Int (1997) 0.78
Conformational landscape of selective mu-opioid agonists in gas phase and in aqueous solution: the fentanyl series. Drug Des Discov (2000) 0.78
An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists. J Pharmacol Exp Ther (2000) 0.78
Effect of acidosis during cold ischemic storage on liver viability following transplantation in the rat. Transplant Proc (1990) 0.78
Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Brain Res Mol Brain Res (1994) 0.78
Alpha(2) adrenoceptor agonists as potential analgesic agents. 1. (Imidazolylmethyl)oxazoles and -thiazoles. J Med Chem (1999) 0.77
Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action. Methods Find Exp Clin Pharmacol (2005) 0.77
Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor. Bioorg Med Chem Lett (2000) 0.77
Selective modulation of elements of the immune system by low molecular weight nucleosides. J Pharmacol Exp Ther (1995) 0.77
Key features of 'environmental fit' that promote good animal welfare in different husbandry systems. Rev Sci Tech (2014) 0.77
D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors. J Pharmacol Exp Ther (1998) 0.77
Exploring the unique pharmacology of a novel opioid receptor, ZFOR1, using molecular modeling and the 'message-address' concept. Protein Eng (2001) 0.77
Immunocytochemical localization of calmodulin in PC12 cells and its possible interaction with histones. Neurochem Int (1995) 0.77
The effect of berbamine derivatives on activated Ca2+-stimulated Mg2+-dependent ATPase in erythrocyte membranes. Biochem J (1987) 0.77
D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors. Mol Pharmacol (1995) 0.77
Midbrain and medullary regulation of respiration and vocalization. Prog Brain Res (1996) 0.77
alpha-Substituted N-(sulfonamido)alkyl-beta-aminotetralins: potent and selective neuropeptide Y Y5 receptor antagonists. J Med Chem (2000) 0.77
Effect of antisense oligodeoxynucleotides directed to individual calmodulin gene transcripts on the proliferation and differentiation of PC12 cells. Antisense Nucleic Acid Drug Dev (1998) 0.76
An analysis of the conserved residues between halobacterial retinal proteins and G-protein coupled receptors: implications for GPCR modeling. J Chem Inf Comput Sci (1996) 0.76
Intravasal injection of formed-in-place silicone rubber as a method of vas occlusion. Int J Androl (1992) 0.76
Effects of the novel calcium channel blocker, McN-5691, on cardiocirculatory dynamics and cardiac output distribution in conscious spontaneously hypertensive rat. J Cardiovasc Pharmacol (1988) 0.76
Temperament and hypothalamic-pituitary-adrenal axis function are related and combine to affect growth, efficiency, carcass, and meat quality traits in Brahman steers. Domest Anim Endocrinol (2011) 0.76
Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine. Neurochem Int (1996) 0.76
Synthesis and biological activity of 5-(4-chlorobenzoyl)-4-(hydroxymethyl)-1-methyl-1H-pyrrole-2-acetic acid, a major metabolite of zomepirac sodium. J Med Chem (1980) 0.75